Contract Services Clinical Research

Thyroscope and TORC to Study Smartphone AI and Orbital Imaging for Thyroid Eye Disease Monitoring

Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database. Thyrosco...

 November 19, 2026 | News

Harbour BioMed Partner Spruce Forms Adrenyx Biosciences to Advance CRHX-101

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...

 November 19, 2026 | News

Delonix Bioworks and A*STAR IDL Collaborate on Vaccines Against Drug-Resistant Klebsiella pneumoniae

Delonix Bioworks, a clinical-stage biotechnology company pioneering next-generation outer membrane vesicle (OMV) vaccines, today announced that it has ente...

 November 18, 2026 | News

China’s NMPA Accepts Akeso’s Ivonescimab Application for First-Line Biliary Tract Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental ...

 November 18, 2026 | News

Innovent’s Zybrivo Receives Positive CHMP Opinion for Advanced Lung Cancer

The opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is Innovent's first European regulatory...

 November 17, 2026 | News

Orphalan Expands Phase 3 Wilson Disease Trial to China

Phase 3 trial evaluates the safety and efficacy of an investigational once-daily formulation of trientine tetrahydrochloride compared to D-penicillamine ...

 November 17, 2026 | News

DIAGENS Introduces iMed-6.0 and CT AI Model Covering 509 Diseases and Imaging Findings

iMed-6.0 brings multimodal reasoning to medical imaging and powers a multi-task CT model, while zero-code tools support specialty AI development. DIAGENS ...

 November 16, 2026 | News

Sanyou Bio Secures Nearly RMB 100 Million in Series C to Advance AI-Driven Drug R&D

Accelerating the Development of an AI-Driven Ecosystem for Innovative Drug R&D and Translation Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") rece...

 November 11, 2026 | News

Innovent’s Tafolecimab Monotherapy Cuts LDL Cholesterol by More Than 60% in Phase 3 Trial

SINTBILO®  (tafolecimab injection) monotherapy achieved significant reduction of LDL-C level, with > 60% mean LDL-C reduction after 12 weeks ...

 November 10, 2026 | News

OncoC4 Reports 33% Response Rate for Cesalatamig in Lung Cancer Resistant to PD-(L)1 Therapy

33% investigator-assessed objective response rate and 90% disease control rate at 10 mg/kg every three weeks in patients with PD-(L)1-resistant/refrac...

 November 09, 2026 | News

Akeso’s Ivonescimab Plus Chemotherapy Granted Priority Review in China for First-Line Biliary Tract Cancer

Akeso, Inc. announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or metastatic biliary tract cancer...

 November 06, 2026 | News

Telix Joins Thera4Care to Advance FAP-Targeted Theranostics Research

Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation...

 November 06, 2026 | News

NUHS, Singtel and Ericsson Expand Partnership to Advance AI-Enabled Healthcare and 6G Research

Extended collaboration will accelerate research and development in advanced connectivity and emerging 5G Advanced & future 6G tec...

 November 05, 2026 | News

InventisBio’s Nomelcitinib Achieves Over 70% PASI 90 Response in Phase III Psoriasis Trial

InventisBio Co., Ltd.  announced that its JH2 selective TYK2 inhibitor nomelcitinib (D-2570) has met both the primary endpoint and the key s...

 November 04, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close